<p>A novel series of peptide-bond-linked fluorochromane-1,2,3-triazole hybrids was synthesized via copper-catalyzed azide-alkyne cycloaddition (CuAAC) click chemistry. The synthetic strategy involved initial coupling of 6-fluorochromane-2-carboxylic acid with propargylamine, followed by conjugation with various 2-azido-<i>N</i>-phenylacetamide derivatives to yield triazole-linked chromane carboxamides <b>(6a-6j)</b>. All final compounds were characterized using MS, IR, <sup>1</sup>H NMR, and <sup>13</sup>C NMR. The compounds were evaluated for their in vitro anti-tubercular activity against the <i>Mycobacterium tuberculosis</i> H37Rv strain. Notably, compound <b>6f</b> bearing a <b>4-CF</b><sub><b>3</b></sub> substituent exhibited the most potent activity with a minimum inhibitory concentration (MIC) of 1.25&#xa0;μg/mL, followed by <b>6&#xa0;g</b> (4-F, 3.12&#xa0;μg/mL) and <b>6&#xa0;h</b> (4-OMe, 6.25&#xa0;μg/mL). Structure–activity relationship analysis suggested that small lipophilic electron-withdrawing groups, particularly CF<sub>3</sub> and F at the para position, enhanced antimycobacterial efficacy. Molecular docking against <i>M. tuberculosis</i> InhA protein (PDB: 4R9S) showed the strongest binding affinity for <b>6f</b> with a docking score of -11.3&#xa0;kcal/mol, followed by <b>6&#xa0;g</b> and <b>6&#xa0;h</b>, each with docking scores of -10.8&#xa0;kcal/mol, supporting their superior experimental activity. DFT analysis of the lead compound <b>6f</b> further indicated favorable electronic characteristics, with calculated HOMO and LUMO energies of -6.216&#xa0;eV and -4.952&#xa0;eV, respectively, suggesting a reactive electronic profile that may support ligand-target interactions. ADMET profiling predicted balanced pharmacokinetic parameters and toxicity profiles, indicating potential drug-likeness.</p> Graphical abstract <p></p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Design and synthesis of peptide-linked fluorochromane-1,2,3-triazoles via click chemistry for anti-tubercular activity: DFT, docking, and ADMET profiling

  • Jignesh Hindocha,
  • Jignesh Kamdar,
  • Suresh Odiya,
  • Jyoti Kuchhadiya,
  • Khushal Kapadiya

摘要

A novel series of peptide-bond-linked fluorochromane-1,2,3-triazole hybrids was synthesized via copper-catalyzed azide-alkyne cycloaddition (CuAAC) click chemistry. The synthetic strategy involved initial coupling of 6-fluorochromane-2-carboxylic acid with propargylamine, followed by conjugation with various 2-azido-N-phenylacetamide derivatives to yield triazole-linked chromane carboxamides (6a-6j). All final compounds were characterized using MS, IR, 1H NMR, and 13C NMR. The compounds were evaluated for their in vitro anti-tubercular activity against the Mycobacterium tuberculosis H37Rv strain. Notably, compound 6f bearing a 4-CF3 substituent exhibited the most potent activity with a minimum inhibitory concentration (MIC) of 1.25 μg/mL, followed by 6 g (4-F, 3.12 μg/mL) and 6 h (4-OMe, 6.25 μg/mL). Structure–activity relationship analysis suggested that small lipophilic electron-withdrawing groups, particularly CF3 and F at the para position, enhanced antimycobacterial efficacy. Molecular docking against M. tuberculosis InhA protein (PDB: 4R9S) showed the strongest binding affinity for 6f with a docking score of -11.3 kcal/mol, followed by 6 g and 6 h, each with docking scores of -10.8 kcal/mol, supporting their superior experimental activity. DFT analysis of the lead compound 6f further indicated favorable electronic characteristics, with calculated HOMO and LUMO energies of -6.216 eV and -4.952 eV, respectively, suggesting a reactive electronic profile that may support ligand-target interactions. ADMET profiling predicted balanced pharmacokinetic parameters and toxicity profiles, indicating potential drug-likeness.

Graphical abstract